Results of treatment of HER 2-positive breast cancer

11 August 2021
3888

The incidence of malignant mammary tumors (MMT) is one of the first among oncological diseases in the world and in Turkmenistan. According to the WHO data, 1 million 700 thousand women fall ill annually in the world [1].

Immunohistochemical (IHC) and other molecular genetic studies are of great importance in determining the biological characteristics of MMT [2-4].

Mive BERDIMYRADOVA, Gulendam POLATOVA, Serdar HAJYYEV, Chary BATYROV, Durdymuhammet PENAYEV, Bahar AGAYEVA, Ayna KAKAJANOVA
Scientific Clinical Center of Oncology
Other news